Change in the Ca2+ response to formyl peptide in HL-60 myeloblastic leukemia cells after the induction of their differentiation by MP-4 myelogenic peptide.
Astashkin
E I
EI
Sechenov Medical Academy, Moscow, Russia.
Suvorov
N I
NI
Mikhailova
A A
AA
Grachev
S V
SV
D000818:Animals; D002118:Calcium / Q000032:analysis / Q000378:metabolism*; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation; D042381:Granulocyte Precursor Cells / Q000187:drug effects / Q000378:metabolism; D018922:HL-60 Cells; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000378:metabolism; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology / Q000627:therapeutic use*
D009842:Oligopeptides; C502954:phenylalanyl-arginyl-prolyl-arginyl-isoleucyl-methionyl-threonyl-proline; C048617:myelopeptides; D009240:N-Formylmethionine Leucyl-Phenylalanine; D002118:Calcium